子宫腺肌瘤剔除术联合曼月乐宫腔置入治疗子宫腺肌瘤疗效分析.doc

子宫腺肌瘤剔除术联合曼月乐宫腔置入治疗子宫腺肌瘤疗效分析 　　[摘要] 目的 对子宫腺肌瘤剔除术联合曼月乐宫腔置入治疗子宫腺肌瘤患者的临床疗效进行研究分析。 方法 随机选取该院2012年2月―2014年3月收治的70例子宫腺肌瘤患者的临床资料，根据患者入院先后顺序将其分为治疗组和对照组，每组均35例，对照组患者行子宫腺肌瘤剔除术治疗，治疗组患者在对照组治疗基础上联合曼月乐宫腔置入治疗，治疗后，观察比较两组患者的痛经VAS评分、月经量以及子宫体积等指标。结果 治疗组患者的痛经VAS评分（1.5±0.3）分、月经量（0.32±0.14） mL以及子宫体积等指标均优于对照组的（2.9±1.4）分、（0.63±0.25）mL以及（152.94±22.10）cm3（P0.05）。结论 临床治疗子宫腺肌瘤患者采取子宫腺肌瘤剔除术联合曼月乐宫腔置入法，能够显著改善患者的痛经，减少术后月经量，并缩小子宫体积。 　　[关键词] 子宫腺肌瘤；子宫腺肌瘤剔除术；曼月乐；宫腔置入 　　[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2015）09（b）-0042-02 　　[Abstract] Objective To analyze the clinical efficacy of resection of endometrioma combined with implantation of mirena intrauterine device in the treatment of patients with endometrioma. Methods The clinical data of 70 patients with endometrioma admitted to our hospital between February 2012 and March 2014 were selected. We divided them into treatment group and control group with 35 in each one according to admission time. The patients in the control group were treated with resection of endometrioma， while those in the treatment group underwent resection of endometrioma combined with implantation of mirena intrauterine device. After treatment， the dysmenorrhea VAS score， menstrual amount， uterine volume were observed and compared between the two groups. Results The dysmenorrhea VAS score （1.5±0.3） vs （2.9±1.4）， the menstrual amount [（0.32±0.14）mL vs （0.63±0.25）mL] and the uterine volume [（152.94±22.10）cm3 vs （167.59±22.35）cm3] were all lower in the treatment group than in the control group with statistical differences（P0.05）. Conclusion In the treatment of patients with endometrioma， resection of endometrioma combined with implantation of mirena intrauterine device can improve dysmenorrheal， reduce postoperative menstrual quantity and uterine volume. 　　[Key words] Endometrioma； Uterine myomectomy； levonorgestrel-releasing intrauterine system； Implantation into uterine cavity 　　近年来，子宫腺肌瘤发病率在不断提高，发病人群日趋年轻化[1]。患者主要伴有继发性痛经、月经量增多、不孕等临床症状。临床治疗子宫腺肌瘤患者主要采取子宫切除术或者药物保守疗法，其中，子宫切除术会对